CLOSTRIDIOIDES DIFFICILE INFECTION TREATMENT MARKET, ANALYSIS

Clostridioides Difficile Infection Treatment Market, by Drug Type (Vancomycin, Metronidazole, Fidaxomicin, and Others (late phase drugs, etc.)), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jan 2023
Code : CMI1492
Pages :182
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Clostridioides Difficile Infection Treatment Market: Key Players

Major players operating in the global clostridioides difficile infection treatment market include Novartis AG, Baxter, ANI Pharmaceuticals, Inc., Mylan N.V., Akorn, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., B. Braun Medical Inc., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceutical PLC, Perrigo Pharmaceutical., Apotex Inc., AbbVie Inc., Ferring Pharmaceuticals, Fresenius Kabi USA., Pfizer Inc., Strides Pharma Science Limited., Sanofi., AstraZeneca., Eli Lilly and Company, Actelion Pharmaceuticals Ltd., and Astellas Pharma.

Clostridioides Difficile Infection Treatment Market, Report Snapshots